PL3108935T3 - Kompozycja zawierająca scirpusynę a i scirpusynę b oraz jej potencjał przeciw otyłości - Google Patents

Kompozycja zawierająca scirpusynę a i scirpusynę b oraz jej potencjał przeciw otyłości

Info

Publication number
PL3108935T3
PL3108935T3 PL16184143T PL16184143T PL3108935T3 PL 3108935 T3 PL3108935 T3 PL 3108935T3 PL 16184143 T PL16184143 T PL 16184143T PL 16184143 T PL16184143 T PL 16184143T PL 3108935 T3 PL3108935 T3 PL 3108935T3
Authority
PL
Poland
Prior art keywords
scirpusin
composition
obesity potential
obesity
potential
Prior art date
Application number
PL16184143T
Other languages
English (en)
Inventor
Muhammed Majeed
Kalyanam Nagabhushanam
Douglas KALMAN
Beena Bhat
Priti VAIDYANATHAN
Sarang Bani
Anjali Pandey
Original Assignee
Muhammed Majeed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Muhammed Majeed filed Critical Muhammed Majeed
Publication of PL3108935T3 publication Critical patent/PL3108935T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/89—Cyperaceae (Sedge family)
    • A61K36/8905—Cyperus (flatsedge)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL16184143T 2012-07-18 2013-07-17 Kompozycja zawierająca scirpusynę a i scirpusynę b oraz jej potencjał przeciw otyłości PL3108935T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261672849P 2012-07-18 2012-07-18
PCT/US2013/050940 WO2014015067A2 (en) 2012-07-18 2013-07-17 Composition comprising scirpusin a and scirpusin b anti-obesity potential thereof
EP16184143.2A EP3108935B1 (en) 2012-07-18 2013-07-17 Composition comprising scirpusin a and scirpusin b and anti-obesity potential thereof
EP13819890.8A EP2744571B1 (en) 2012-07-18 2013-07-17 Scirpusin a and scirpusin b and anti-obesity potential thereof

Publications (1)

Publication Number Publication Date
PL3108935T3 true PL3108935T3 (pl) 2020-10-05

Family

ID=49947067

Family Applications (2)

Application Number Title Priority Date Filing Date
PL13819890T PL2744571T3 (pl) 2012-07-18 2013-07-17 Sposób hamowania adipogenezy za pomocą kompozycji zawierającej scirpusynę a i scirpusynę b i potencjał przeciwotyłościowy scirpusyny a i scirpusyny b
PL16184143T PL3108935T3 (pl) 2012-07-18 2013-07-17 Kompozycja zawierająca scirpusynę a i scirpusynę b oraz jej potencjał przeciw otyłości

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL13819890T PL2744571T3 (pl) 2012-07-18 2013-07-17 Sposób hamowania adipogenezy za pomocą kompozycji zawierającej scirpusynę a i scirpusynę b i potencjał przeciwotyłościowy scirpusyny a i scirpusyny b

Country Status (11)

Country Link
US (1) US9387193B2 (pl)
EP (2) EP2744571B1 (pl)
JP (1) JP6135761B2 (pl)
KR (2) KR101717889B1 (pl)
AU (1) AU2013292593B2 (pl)
CA (1) CA2883176C (pl)
EA (1) EA025578B1 (pl)
NZ (1) NZ622927A (pl)
PH (1) PH12015500349B1 (pl)
PL (2) PL2744571T3 (pl)
WO (1) WO2014015067A2 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2835306T3 (es) 2015-05-06 2021-06-22 Sami Labs Ltd Composición que comprende escirpusina a y escirpusina b y potencial contra la obesidad de la misma
CN104910172B (zh) * 2015-06-24 2017-07-11 辽宁中医药大学 五种二苯乙烯三聚体的制备方法及其应用
WO2021146651A1 (en) * 2020-01-17 2021-07-22 Muhammed Majeed Process and compositions for enhancing energy expenditure
CN112666277B (zh) * 2020-11-30 2022-07-08 四川新绿色药业科技发展有限公司 一种香附药材、饮片、标准汤剂、配方颗粒hplc特征图谱的构建及检测方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8017634B2 (en) * 2003-12-29 2011-09-13 President And Fellows Of Harvard College Compositions for treating obesity and insulin resistance disorders
US20060110479A1 (en) * 2004-11-24 2006-05-25 Mitra Shankar K Natural composition for curing hepatitis-B, methods for making the same and pharmaceutical formulations thereof
KR20080050794A (ko) * 2006-12-04 2008-06-10 장용훈 복합 생약 추출물(ｍｓｔ)을 함유하는 비만의 예방 및치료용 조성물
CN101274050B (zh) * 2007-03-28 2011-05-18 复旦大学 荆三棱在制备治疗艾滋病药物中的用途
WO2011033524A2 (en) * 2009-08-04 2011-03-24 Laila Nutraceuticals Agents from ficus hispida for the amelioration of metabolic syndrome and related diseases
KR20110087808A (ko) * 2010-01-27 2011-08-03 이경준 복합 생약추출물을 함유하는 비만의 예방과 치료용 조성 물질의 개발 및 체질별 간 기능 개선, 중성지방 저하를 동시에 치료하는 조성물 개발
KR101188581B1 (ko) * 2010-06-09 2012-10-05 동국대학교 경주캠퍼스 산학협력단 향부자 메탄올 추출물을 유효성분으로 함유하는 패혈증 예방 또는 치료용 조성물
US20120029085A1 (en) * 2010-07-29 2012-02-02 Mackay Jon Stabilization of quinol composition such as catecholamine drugs

Also Published As

Publication number Publication date
PH12015500349A1 (en) 2015-04-20
EP3108935B1 (en) 2020-04-22
JP2015527324A (ja) 2015-09-17
US20140024706A1 (en) 2014-01-23
WO2014015067A3 (en) 2014-04-10
NZ622927A (en) 2017-03-31
EA025578B1 (ru) 2017-01-30
KR20160018878A (ko) 2016-02-17
KR20140065438A (ko) 2014-05-29
WO2014015067A4 (en) 2014-05-30
AU2013292593A1 (en) 2014-04-17
PL2744571T3 (pl) 2020-04-30
PH12015500349B1 (en) 2015-04-20
KR101717889B1 (ko) 2017-03-17
EP2744571B1 (en) 2019-10-16
EA201490752A1 (ru) 2016-05-31
EP2744571A2 (en) 2014-06-25
AU2013292593A8 (en) 2014-05-01
CA2883176C (en) 2020-12-01
AU2013292593B2 (en) 2018-04-26
JP6135761B2 (ja) 2017-05-31
US9387193B2 (en) 2016-07-12
KR101600212B1 (ko) 2016-03-04
EP2744571A4 (en) 2015-10-21
CA2883176A1 (en) 2014-01-23
WO2014015067A2 (en) 2014-01-23
EP3108935A1 (en) 2016-12-28

Similar Documents

Publication Publication Date Title
HK1202545A1 (en) New diazaspirocycloalkane and azaspirocycloalkane
HK1199023A1 (en) Substituted benzothienylpyrrolotriazines and uses thereof
HK1200822A1 (en) Substituted dipyridylamines and uses thereof
IL237309A0 (en) Benzocyclooctyne compounds and uses thereof
EP2885318A4 (en) PEPTIDE-DENDRIMER CONJUGATES AND USES THEREOF
HK1210949A1 (en) Combinations and uses thereof
HK1207817A1 (en) Composition comprising herbs
PL2745849T3 (pl) Kompozycja polideoksyrybonukleotydów i jej zastosowanie
IL238532A0 (en) Synbiotic compound and its use
HK1210809A1 (en) Beta-hexosyl-transferases and uses thereof
EP2874641A4 (en) COMPOSITIONS INCREASING THE GLUTATHION RATE AND USES THEREOF
PL3108935T3 (pl) Kompozycja zawierająca scirpusynę a i scirpusynę b oraz jej potencjał przeciw otyłości
EP2822601A4 (en) MIRNA AND USES THEREOF
GB201214169D0 (en) New compounds and uses thereof
IL238531A0 (en) Synbiotic compound and its use
LT2830587T (lt) Odą apsauganti ir odos pusiausvyrą palaikanti kompozicija
GB201219884D0 (en) New composition and preparation thereof
GB201222541D0 (en) Kiddibidet and pottibidet
SG10201508411UA (en) A rotor-arm assembly and a multi-rotorcraft
GB201222342D0 (en) Compounds and uses thereof
IL218974A0 (en) Conaction bitwen coutch and playels
GB201202021D0 (en) Co-sleeper and breastfeeder
AU2012228V (en) GFLEUWHMTN Leucanthemum xsuperbum
GB201206055D0 (en) New compounds and uses